Deciphering the role of Th2-multipotent progenitor cells in chronic allergic inflammation

Currently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen exposure, underlie many chronic diseases in humans, including asthma, atopic dermatitis, ulcerative colitis and more.

Patient aggression causes lasting harm to medical receptionists

University of Queensland research has found verbal and physical abuse of medical receptionists by patients is rife, and causing lasting harm.

July 7, 2023

FDA authorizes Pi-Cardia’s valve-in-valve TAVR device

Dive Brief: Pi-Cardia received Food and Drug Administration clearance for a device designed to reduce the risk of coronary obstruction in valve-in-valve transcatheter aortic valve

October 3, 2024

Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.”

January 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.